EBIT at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s EBIT?
- Denali Therapeutics Inc. (DNLI) reported EBIT of -$137.36M in Q1 2026.
- How has Denali Therapeutics Inc.'s EBIT changed year-over-year?
- Denali Therapeutics Inc.'s EBIT increased by 5.6% year-over-year, from -$145.58M to -$137.36M.
- What is the long-term trend for Denali Therapeutics Inc.'s EBIT?
- Over 4 years (2021 to 2025), Denali Therapeutics Inc.'s EBIT has grown at a 17.1% compound annual growth rate (CAGR), from -$295.75M to -$555.34M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.